The Transcriptional Effect of WT1 Is Modulated by Choice of Expression Vector (*)

The WT1 Wilms' tumor suppressor gene encodes a zinc finger transcription factor which plays a critical role in renal and genitourinary development. The WT1 protein was reported to both activate and repress transcription. We found that the transcriptional effect of WT1 on the Egr1 promoter could be modulated by the use of expression vectors containing different promoters. WT1 activated the Egr1 promoter when expression of WT1 was driven by the Rous sarcoma virus promoter. In contrast, a cytomegalovirus (CMV) promoter-containing WT1 expression vector repressed the Egr1 promoter. However, WT1 activated transcription of a simple test promoter, EGR3tkCAT, regardless of the expression vector used. Co-transfection of the parental CMV-based vector strongly depressed the basal activity of the Egr1-CAT reporter, suggesting that the CMV promoter competes with the Egr1 promoter for transcription factors or co-factors which may be required for activation by WT1. In support of this hypothesis, WT1 was converted from an activator to a repressor by co-transfection of an excess of the parental CMV-based vector. These results provide an important caveat to the interpretation of co-transfection studies and confirm the bi-functional nature of the WT1 transcription factor.

[1]  D. Haber,et al.  WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. , 1995, The EMBO journal.

[2]  H. Werner,et al.  Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression , 1995, Molecular and cellular biology.

[3]  J. Licht,et al.  WT1-mediated Transcriptional Activation Is Inhibited by Dominant Negative Mutant Proteins (*) , 1995, The Journal of Biological Chemistry.

[4]  Z. Wang,et al.  WT1, the Wilms' tumor suppressor gene product, represses transcription through an interactive nuclear protein. , 1995, Oncogene.

[5]  J. Morris,et al.  Repression of Pax-2 by WT1 during normal kidney development. , 1995, Development.

[6]  P. Romaniuk,et al.  High affinity binding sites for the Wilms' tumour suppressor protein WT1. , 1995, Nucleic acids research.

[7]  F. Rauscher,et al.  Novel replication inhibitory function of the developmental regulator/transcription repressor protein WT1 encoded by the Wilms' tumor gene. , 1994, Oncogene.

[8]  K. Malik,et al.  Autoregulation of the human WT1 gene promoter , 1994, FEBS letters.

[9]  J. Licht,et al.  Mapping and mutagenesis of the amino-terminal transcriptional repression domain of the Drosophila Krüppel protein , 1994, Molecular and cellular biology.

[10]  R. Tjian,et al.  TBP-TAF complexes: selectivity factors for eukaryotic transcription. , 1994, Current opinion in cell biology.

[11]  M. Sporn,et al.  Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product. , 1994, Molecular endocrinology.

[12]  V. Sukhatme,et al.  Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site. , 1994, The Journal of biological chemistry.

[13]  C. Terhorst,et al.  CD3 delta enhancer. CREB interferes with the function of a murine CD3-delta A binding factor (M delta AF). , 1994, Journal of immunology.

[14]  S. Madden,et al.  The Wilms' tumor suppressor gene WT1 is negatively autoregulated. , 1994, The Journal of biological chemistry.

[15]  J. Licht,et al.  Selective repression of transcriptional activators at a distance by the Drosophila Krüppel protein. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[16]  X. Xia,et al.  Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus. , 1993, The Journal of biological chemistry.

[17]  V. Sukhatme,et al.  A novel repression module, an extensive activation domain, and a bipartite nuclear localization signal defined in the immediate-early transcription factor Egr-1 , 1993, Molecular and cellular biology.

[18]  D. Cook,et al.  A structure-function analysis of transcriptional repression mediated by the WT1, Wilms' tumor suppressor protein. , 1993, Oncogene.

[19]  V. Sukhatme,et al.  Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Amy Bernard,et al.  Physical and functional interaction between WT1 and p53 proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Z. Wang,et al.  The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains. , 1993, The Journal of biological chemistry.

[22]  T. Graf,et al.  Myb and NF-M: combinatorial activators of myeloid genes in heterologous cell types. , 1993, Genes & development.

[23]  J. Wagner,et al.  Nerve growth factor induces transcription of NGFIA through complex regulatory elements that are also sensitive to serum and phorbol 12-myristate 13-acetate. , 1993, Molecular endocrinology.

[24]  D. Sens,et al.  The G401 cell line, utilized for studies of chromosomal changes in Wilms' tumor, is derived from a rhabdoid tumor of the kidney. , 1993, The American journal of pathology.

[25]  J. Heath,et al.  Involvement of AP1 and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinases-1 (TIMP-1) transcription. , 1992, Biochimica et biophysica acta.

[26]  D. Bonthron,et al.  Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Z. Wang,et al.  The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. , 1992, The Journal of biological chemistry.

[28]  G I Bell,et al.  Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. , 1992, Science.

[29]  P. Sharp,et al.  A dominant mutation in the Wilms tumor gene WT1 cooperates with the viral oncogene E1A in transformation of primary kidney cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Gossen,et al.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Ghosh,et al.  TFD: the transcription factors database. , 1992, Nucleic acids research.

[32]  V. Sukhatme,et al.  Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus. , 1991, Oncogene.

[33]  D. Housman,et al.  Alternative splicing and genomic structure of the Wilms tumor gene WT1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Ikeguchi,et al.  Structural and functional analyses of the promoter of the murine multidrug resistance gene mdr3/mdr1a reveal a negative element containing the AP-1 binding site. , 1991, DNA and cell biology.

[35]  H. Jäckle,et al.  Concentration-dependent transcriptional activation or repression by Krüppel from a single binding site , 1991, Nature.

[36]  S. Madden,et al.  Transcriptional repression mediated by the WT1 Wilms tumor gene product. , 1991, Science.

[37]  D. Housman,et al.  Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development , 1991, Molecular and cellular biology.

[38]  P. Monaci,et al.  Synergistic trans‐activation of the human C‐reactive protein promoter by transcription factor HNF‐1 binding at two distinct sites. , 1990, The EMBO journal.

[39]  T. Curran,et al.  Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. , 1990, Science.

[40]  T. Curran,et al.  Transcriptional activation and repression by Fos are independent functions: the C terminus represses immediate-early gene expression via CArG elements , 1990, Molecular and cellular biology.

[41]  R. Koski,et al.  Identification and characterization of the Egr-1 gene product, a DNA-binding zinc finger protein induced by differentiation and growth signals , 1990, Molecular and cellular biology.

[42]  H. Land,et al.  A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. , 1990, Nucleic acids research.

[43]  A. Poustka,et al.  Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping , 1990, Nature.

[44]  D. Housman,et al.  Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus , 1990, Cell.

[45]  M. Ptashne.  How eukaryotic transcriptional activators work , 1988, Nature.

[46]  V. Sukhatme,et al.  5' flanking sequence and genomic structure of Egr-1, a murine mitogen inducible zinc finger encoding gene. , 1988, Nucleic acids research.

[47]  Eileen D. Adamson,et al.  A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization , 1988, Cell.

[48]  Michael Boshart,et al.  A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus , 1985, Cell.

[49]  A. Papageorge,et al.  727 ISOLATION OF FOUR UNUSUAL PEDIATRIC SOLID TUMOR CELL LINES , 1978, Pediatric Research.

[50]  J. L. Messina,et al.  One of three CCArGG box/serum response elements of the beta-actin gene is an insulin-responsive element. , 1995, Endocrinology.

[51]  L. Sealy,et al.  Identification of a third protein factor which binds to the Rous sarcoma virus LTR enhancer: possible homology with the serum response factor. , 1990, Virology.